23.03.2013 Views

White Guide and Orange Guide Formatting Project - Pfizer

White Guide and Orange Guide Formatting Project - Pfizer

White Guide and Orange Guide Formatting Project - Pfizer

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Signing Customer Confidentiality Agreements<br />

State <strong>and</strong> Other Privacy Laws<br />

<strong>Orange</strong> <strong>Guide</strong> – Chapter 8: Privacy: Protecting Personal Information<br />

Q. If an HCP insists that I sign a facility’s Confidentiality Agreement, even after I<br />

sign <strong>and</strong> show him or her <strong>Pfizer</strong>’s Privacy Pledge <strong>and</strong> Patient Health<br />

Information Confidentiality Agreement, can I sign what the HCP wants me to<br />

sign?<br />

A. Maybe. Sometimes these agreements are acceptable to sign, but you should<br />

never do so unless your Regional Attorney has first reviewed <strong>and</strong> approved<br />

the agreement.<br />

Although many of <strong>Pfizer</strong>’s activities are not covered by HIPAA, some of our activities still may be<br />

covered by other laws <strong>and</strong> regulations, including state privacy laws. Therefore, except as expressly<br />

authorized by your manager or Regional Attorney, you must avoid collecting, maintaining, or<br />

using Sensitive Personal Information. If you inadvertently come into contact with Sensitive Personal<br />

Information or are asked to collect it, you should contact your Regional Attorney immediately to<br />

discuss <strong>Pfizer</strong>’s policies regarding safeguarding such information.<br />

Steps to Protect Patient Privacy<br />

Avoid Intentional <strong>and</strong> Inadvertent Disclosure of Sensitive Personal Information<br />

HCPs are subject to many restrictions regarding the use <strong>and</strong> disclosure of Sensitive Personal<br />

Information. Generally, HCPs are not permitted to disclose a patient’s SPI to a third party unless they<br />

receive prior written authorization from the patient. You must avoid situations in which you may be<br />

exposed to SPI without an individual’s consent. In the event an HCP or other person exposes you to SPI,<br />

you should not document or reproduce the information in any media or form. You must strictly<br />

maintain the confidentiality of such information in accordance with <strong>Pfizer</strong>’s policy of safeguarding the<br />

privacy of all patient-related data. Even if an individual has consented to a use or disclosure of SPI, such<br />

as during a mentorship, you must still abide by the rules discussed in this Chapter <strong>and</strong> consult your<br />

Regional Attorney to ensure compliance with <strong>Pfizer</strong> policies <strong>and</strong> applicable laws regarding the use,<br />

disclosure, <strong>and</strong> destruction of any SPI to which you are exposed.<br />

140<br />

Rev. 09/12<br />

Page 7 of 18

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!